Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel

被引:34
|
作者
Jin, Bo [1 ]
Liu, Yanping [2 ]
Wang, Haijiang [1 ]
机构
[1] Xinjiang Med Univ, Xinjiang Tumor Hosp, Dept Gastroenteropathy Surg, Affiliated Hosp 3, Urumqi 830011, Xinjiang, Peoples R China
[2] Xinjiang Med Univ, Xinjiang Tumor Hosp, Dept Anesthesiol, Affiliated Hosp 3, Urumqi 830011, Xinjiang, Peoples R China
关键词
miRNA-21; Gastric cancer; P-glycoprotein; BREAST-CANCER; PHASE-II; 2ND-LINE CHEMOTHERAPY; MULTIDRUG-RESISTANCE; MICRORNA EXPRESSION; P-GLYCOPROTEIN; INHIBITION; CHEMOSENSITIVITY; COMBINATION; INVOLVEMENT;
D O I
10.1007/s12013-014-0450-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of drug resistance has largely limited the clinical outcome of anti-cancer treatment. Recent work has highlighted the involvement of non-coding RNAs, microRNAs (miRNAs), in cancer development. The present study aimed to investigate the role of miR-21 in the development of drug resistance to paclitaxel in gastric cancer cells. Our study found that the expression of miR-21 upregulated in the paclitaxel resistant cell line SGC7901/paclitaxel compared to its parental line SGC7901. Moreover, over-expression of miR-21 significantly decreased antiproliferative effects and apoptosis induced by paclitaxel, while knockdown of miR-21 dramatically increased antiproliferative effects and apoptosis induction by paclitaxel. Moreover, our results demonstrated that miR-21 may modulate the sensitivity to PTX, at least in part, by regulating the expression of P-glycoprotein.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 50 条
  • [1] Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
    Bo Jin
    Yanping Liu
    Haijiang Wang
    Cell Biochemistry and Biophysics, 2015, 72 : 275 - 282
  • [2] MiRNA-21, a Potential Prognostic Marker for Human Gastric Cancer
    Truong, C. D.
    Feng, W.
    Li, W.
    Khoury, T.
    Alrawi, S.
    Yao, J.
    Xie, K.
    Rossi, S.
    Calin, G.
    Tan, D.
    LABORATORY INVESTIGATION, 2009, 89 : 150A - 150A
  • [3] MiRNA-21, a Potential Prognostic Marker for Human Gastric Cancer
    Truong, C. D.
    Feng, W.
    Khoury, T.
    Alrawi, S.
    Yao, J.
    Xie, K.
    Rossi, S.
    Calin, G.
    Tan, D.
    MODERN PATHOLOGY, 2009, 22 : 150A - 150A
  • [4] SERUM MIRNA-21 EXPRESSION IN GASTRIC CANCER PATIENTS AS A SCREENING BIOMARKER
    Kurdistani, Z. Karimi
    Mahdian, R.
    Darbouy, M.
    Oghalaie, A.
    Saberi, S.
    Esmaili, M.
    Abdirad, A.
    Hosseini, M. Eshagh
    Mohagheghi, M.
    Mohammadi, M.
    HELICOBACTER, 2014, 19 : 94 - 94
  • [5] Curcumin suppresses gastric cancer biological activity by regulation of miRNA-21: an in vitro study
    Liu, Weiwei
    Huang, Meixiang
    Zou, Qiuqiong
    Lin, Wanyi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5820 - 5829
  • [6] miRNA-21 promotes gastric cancer growth by adjusting prostaglandin E2
    Qi, R.
    Wang, D-T.
    Xing, L-F.
    Wu, Z-J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 1929 - 1936
  • [7] Naringin sensitizes human prostate cancer cells to paclitaxel therapy
    Erdogan, Suat
    Doganlar, Oguzhan
    Doganlar, Zeynep B.
    Turkekul, Kader
    PROSTATE INTERNATIONAL, 2018, 6 (04) : 126 - 135
  • [8] miRNA-21 as a novel therapeutic target in lung cancer
    Markou, Athina
    Zavridou, Martha
    Lianidou, Evi S.
    LUNG CANCER-TARGETS AND THERAPY, 2016, 7 : 19 - 27
  • [9] LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer
    Dan, Jie
    Wang, Jian
    Wang, Yonghong
    Zhu, Mingjie
    Yang, Xiaojun
    Peng, Zhong
    Jiang, Hongyuan
    Chen, Lei
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 : 931 - 938
  • [10] Role of miRNA-21 in cancer and its application in electrochemical bioanalysis
    Negahdary, Masoud
    BIOANALYSIS, 2024, 16 (19-20) : 997 - 1000